Resistente Bakterien: Wie gefährlich sind die Ferien-Souvenirs? [TV Broadcast] (Publications)
Bakterien, die gegen mehrere Antibiotika unempfindlich sind: Ein wachsendes Problem für die moderne Medizin. Besonders oft fängt man sich solche «Superbugs» in Spitälern ein. Sie können aber auch unbe
Menopause as a predictor of new-onset asthma: a longitudinal Northern European population study (Publications)
BACKGROUND: There is limited and conflicting evidence on the effect of menopause on asthma. OBJECTIVES: We sought to study whether the incidence of asthma and respiratory symptoms differ by menopausal
The spatial and seasonal distribution of <em>Bulinus truncatus</em>, <em>Bulinus forskalii</em> and <em>Biomphalaria pfeifferi</em>, the intermediate... (Publications)
There is a paucity of epidemiological and malacological data pertaining to schistosomiasis in Chad. In view of a recently articulated elimination agenda, a deeper understanding of the spatio-temporal
Open Malaria : a simulator program for studying malaria epidemiology and the impacts of interventions against malaria [Software] (Publications)
OpenMalaria is an open source C++ program for simulating malaria epidemiology and the impacts on that epidemiology of interventions against malaria. It is based on microsimulations of
Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial (Publications)
BACKGROUND: Specific physical loading leads to enhanced bone development during childhood. A general physical activity program mimicking a real-life situation was successful at increasing general phys
cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011 (Publications)
Comprehensive information on combined antiretroviral therapy (cART) regimens in rural Sub-Saharan Africa over time is scarce, particularly on the use of stavudine (d4T) and second-line regimens. Since
Match-making for pasaconazole through systems thinking (Publications)
Currently available drugs for Chagas' disease are limited by toxicity and low efficacy in the chronic stage. Posaconazole, the most advanced new anti-chagasic drug candidate, did not fully confirm its